All lobbying filings
CAPITOL COUNSEL LLC
Lobbying for IPSEN BIOPHARMACEUTICALS, INC. · Biopharmaceutical company.
Filing
3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 17, 2025
Income
$30,000.00
What the client paid this registrant for the period.
Client based in
Massachusetts
Lobbyists on this filing
1
-
JOHN MARTIN New on this filingPreviously held: Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton.
Government bodies contacted
2
Lobbying activity
2
Ensure Medicare beneficiary access to Medicare covered prescription drugs and enable beneficiaries to spread cost-sharing requirements, including monitor implementation of related provisions in the Inflation Reduction Act, P.L. 117-169.
Issues related to international tax.